Leukemia, Myelocytic, Acute
|
0.350 |
Biomarker
|
disease |
BEFREE |
Although our study suggests a role for MN1 gene and PTEN genes in AML, we could not recommend their use as routine diagnostic and prognostic markers for AML in Egyptian population.
|
27983532 |
2017 |
Leukemia, Myelocytic, Acute
|
0.350 |
AlteredExpression
|
disease |
BEFREE |
Meningioma 1 (MN1) gene overexpression has been reported in acute myeloid leukaemia (AML) patients and identified as a negative prognostic factor.
|
27765915 |
2016 |
Leukemia, Myelocytic, Acute
|
0.350 |
Biomarker
|
disease |
BEFREE |
MN1 gene and MN1-associated microRNAs provide clinical prognosis of AML patients and may refine their molecular risk classification.
|
23515710 |
2013 |
Leukemia, Myelocytic, Acute
|
0.350 |
Biomarker
|
disease |
CTD_human |
Micro-RNAs and copy number changes: new levels of gene regulation in acute myeloid leukemia.
|
19822134 |
2010 |
Leukemia, Myelocytic, Acute
|
0.350 |
AlteredExpression
|
disease |
LHGDN |
MN1 overexpression is an important step in the development of inv(16) AML.
|
17525718 |
2007 |
Leukemia, Myelocytic, Acute
|
0.350 |
Biomarker
|
disease |
BEFREE |
A new complex rearrangement involving the ETV6, LOC115548, and MN1 genes in a case of acute myeloid leukemia.
|
15334551 |
2004 |
Global developmental delay
|
0.310 |
GeneticVariation
|
disease |
BEFREE |
Craniofacial abnormalities and developmental delay in two families with overlapping 22q12.1 microdeletions involving the MN1 gene.
|
25810350 |
2015 |
Intellectual Disability
|
0.310 |
GeneticVariation
|
group |
BEFREE |
We report on four patients (two families) with craniofacial abnormalities and intellectual disability with overlapping microdeletions that span the MN1 gene.
|
25810350 |
2015 |
Global developmental delay
|
0.310 |
Biomarker
|
disease |
GENOMICS_ENGLAND |
Targeted disruption of the Mn1 oncogene results in severe defects in development of membranous bones of the cranial skeleton.
|
15870292 |
2005 |
Intellectual Disability
|
0.310 |
Biomarker
|
group |
GENOMICS_ENGLAND |
Targeted disruption of the Mn1 oncogene results in severe defects in development of membranous bones of the cranial skeleton.
|
15870292 |
2005 |
Acute Myeloid Leukemia, M1
|
0.300 |
Biomarker
|
disease |
CTD_human |
Micro-RNAs and copy number changes: new levels of gene regulation in acute myeloid leukemia.
|
19822134 |
2010 |
Acute Myeloid Leukemia (AML-M2)
|
0.300 |
Biomarker
|
disease |
CTD_human |
Micro-RNAs and copy number changes: new levels of gene regulation in acute myeloid leukemia.
|
19822134 |
2010 |
Craniosynostosis
|
0.300 |
Biomarker
|
disease |
GENOMICS_ENGLAND |
Targeted disruption of the Mn1 oncogene results in severe defects in development of membranous bones of the cranial skeleton.
|
15870292 |
2005 |
Feeding difficulties
|
0.300 |
Biomarker
|
phenotype |
GENOMICS_ENGLAND |
Targeted disruption of the Mn1 oncogene results in severe defects in development of membranous bones of the cranial skeleton.
|
15870292 |
2005 |
Polymicrogyria
|
0.300 |
Biomarker
|
disease |
GENOMICS_ENGLAND |
Targeted disruption of the Mn1 oncogene results in severe defects in development of membranous bones of the cranial skeleton.
|
15870292 |
2005 |
hearing impairment
|
0.300 |
Biomarker
|
phenotype |
GENOMICS_ENGLAND |
Targeted disruption of the Mn1 oncogene results in severe defects in development of membranous bones of the cranial skeleton.
|
15870292 |
2005 |
Central hypotonia
|
0.300 |
Biomarker
|
phenotype |
GENOMICS_ENGLAND |
Targeted disruption of the Mn1 oncogene results in severe defects in development of membranous bones of the cranial skeleton.
|
15870292 |
2005 |
Abnormal corpus callosum morphology
|
0.300 |
Biomarker
|
phenotype |
GENOMICS_ENGLAND |
Targeted disruption of the Mn1 oncogene results in severe defects in development of membranous bones of the cranial skeleton.
|
15870292 |
2005 |
Abnormality of the cerebellum
|
0.300 |
Biomarker
|
group |
GENOMICS_ENGLAND |
Targeted disruption of the Mn1 oncogene results in severe defects in development of membranous bones of the cranial skeleton.
|
15870292 |
2005 |
Deformity of facial bone
|
0.300 |
Biomarker
|
disease |
GENOMICS_ENGLAND |
Targeted disruption of the Mn1 oncogene results in severe defects in development of membranous bones of the cranial skeleton.
|
15870292 |
2005 |
Abnormality of the face
|
0.300 |
Biomarker
|
phenotype |
GENOMICS_ENGLAND |
Targeted disruption of the Mn1 oncogene results in severe defects in development of membranous bones of the cranial skeleton.
|
15870292 |
2005 |
Familial meningioma
|
0.300 |
Biomarker
|
disease |
CTD_human |
|
|
|
Forced expiratory volume function
|
0.100 |
GeneticVariation
|
phenotype |
GWASCAT |
New genetic signals for lung function highlight pathways and chronic obstructive pulmonary disease associations across multiple ancestries.
|
30804560 |
2019 |
Finding of Mean Corpuscular Hemoglobin
|
0.100 |
GeneticVariation
|
phenotype |
GWASCAT |
Leveraging Polygenic Functional Enrichment to Improve GWAS Power.
|
30595370 |
2019 |
peak expiratory flow (procedure)
|
0.100 |
GeneticVariation
|
phenotype |
GWASCAT |
New genetic signals for lung function highlight pathways and chronic obstructive pulmonary disease associations across multiple ancestries.
|
30804560 |
2019 |